Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men

Journal of Infectious Diseases

Volumn 207, Issue 3, 2013, Pages 392-401

  Sahasrabuddhe, Vikrant V ^a   Castle, Philip E ^b   Follansbee, Stephen ^c   Borgonovo, Sylvia ^c   Tokugawa, Diane ^c   Schwartz, Lauren M ^a   Lorey, Thomas S ^c   Lamere, Brandon J ^e   Gage, Julia C ^a   Fetterman, Barbara ^c   Boyle, Sean ^f   Sadorra, Mark ^f   Tang, Scott Dahai ^f   Darragh, Teresa M ^d   Wentzensen, Nicolas ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c KAISER PERMANENTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DIVISION OF RESEARCH   (United States)

^f ROCHE MOLECULAR SYSTEMS   (United States)

Author keywords

Anal cancer; anal intraepithelial neoplasia; attribution; genotypes; human immunodeficiency virus; human papillomavirus; men who have sex with men

Indexed keywords

ANTIRETROVIRUS AGENT; WART VIRUS VACCINE;

ADULT; AGED; ANUS CARCINOMA; ARTICLE; CANCER RISK; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOLOGY; DRUG EFFICACY; GENE FUNCTION; GENETIC RISK; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 42; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 61; HUMAN PAPILLOMAVIRUS TYPE 62; HUMAN PAPILLOMAVIRUS TYPE 70; HUMAN PAPILLOMAVIRUS TYPE 84; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SEROCONVERSION; VACCINATION; VIRUS CARCINOGENESIS; VIRUS GENE; VIRUS IDENTIFICATION; VIRUS LOAD; WART VIRUS; CAUSAL ATTRIBUTION; CHILD; GENOTYPE; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 68; MEN WHO HAVE SEX WITH MEN; PREVALENCE; PROPHYLAXIS; YOUNG ADULT;

ADULT; AGED; ANUS NEOPLASMS; CARCINOMA IN SITU; COINFECTION; CROSS-SECTIONAL STUDIES; GENOTYPE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PREVALENCE; SEXUAL BEHAVIOR;

EID: 84872042053     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis694     Document Type: Article

References (25)

1. Silverberg MJ, Lau B, Justice AC, et al. Risk of Anal Cancer in HIVInfected and HIV-Uninfected Individuals in North America. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 2012; 54:1026-34.
2. Palefsky JM, Holly EA, Efirdc JT, et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 2005; 19:1407-14.
3. Machalek DA, Poynten M, Jin F, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. The Lancet Oncology 2012; 13:487-500.
4. Wentzensen N. Screening for anal cancer: end points needed. The Lancet Oncology 2012; 13:438-40.
5. Gage JC, Ghosh A, Borgonovo S, et al. A comparison of dacron versus Flocked nylon swabs for anal cytology specimen collection. Acta Cytologica 2011; 55:364-7.
6. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA : The Journal of the American Medical Association 2002; 287:2114-9.
7. Darragh TM, Tokugawa D, Castle PE, et al. Interrater agreement of anal cytology. [published online ahead of print July 18, 2012]. Cancer Cytopathol 2012. doi: 10. 1002/cncy. 21218.
8. Kornegay JR, Roger M, Davies PO, et al. International proficiency study of a consensus L1 PCR assay for the detection and typing of human papillomavirus DNA: evaluation of accuracy and intralaboratory and interlaboratory agreement. J Clin Microbiol 2003; 41: 1080-6.
9. Bouvard V, Baan R, Straif K, et al. A review of human carcinogens-Part B: biological agents. The Lancet Oncology 2009; 10:321-2.
10. Wentzensen N, Wilson LE, Wheeler CM, et al. Hierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage study. Cancer Research 2010; 70:8578-86.
11. Wentzensen N, Schiffman M, Dunn T, et al. Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early end points and determinants. Int J Cancer 2009; 125:2151-8.
12. Insinga RP, Liaw KL, Johnson LG, Madeleine MM. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev 2008; 17: 1611-22.
13. Miguez MJ, Burbano-Levy X, Rosenberg R, Malow R. The importance of HIV status and gender when designing prevention strategies for anal cancer. J Assoc Nurses AIDS Care 2011; 22:454-64.
14. Czoski-Murray C, Karnon J, Jones R, Smith K, Kinghorn G. Cost-effectiveness of screening high-risk HIV-positive men who have sex with men (MSM) and HIV-positive women for anal cancer. Health Technol Assess 2010; 14:iii-iv., ix-x, 1-101.
15. Lam JM, Hoch JS, Tinmouth J, Sano M, Raboud J, Salit IE. Cost-effectiveness of screening for anal precancers in HIV-positive men. AIDS 2011; 25:635-42.
16. Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011; 60:1705-8.
17. Darragh TM, Winkler B. Anal cancer and cervical cancer screening: key differences. Cancer Cytopathol 2011; 119:5-19.
18. Berry JM, Palefsky JM, Jay N, Cheng SC, Darragh TM, Chin-Hong PV. Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia. Dis Colon Rectum 2009; 52:239-47.
19. Swedish KA, Lee EQ, Goldstone SE. The changing picture of highgrade anal intraepithelial neoplasia in men who have sex with men: the effects of 10 years of experience performing high-resolution anoscopy. Dis Colon Rectum 2011; 54:1003-7.
20. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009; 124:1626-36.
21. Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, et al. Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. British Journal of Cancer 2007; 96:1480-3.
22. Clifford GM, Goncalves MA, Franceschi S. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS 2006; 20:2337-44.
23. Palefsky J. Human papillomavirus and anal neoplasia. Curr HIV/AIDS Rep 2008; 5:78-85.
24. van der Marel J, Quint WG, Schiffman M, et al. Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16. Int J Cancer 2012; 131:E946-53.
25. Kim JJ. Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis. Lancet Infect Dis 2010; 10:845-52.